FibroBiologics Analyst Price Targets

Wall Street analyst price targets and consensus rating for FibroBiologics (FBLG).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

3Buy

2Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$189Upside to Avg. PT+16596.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 4, 2026	HC Wainwright & Co.	Matthew Caufield	PT Cut	Buy	$8→$6
May 4, 2026	Maxim Group	Michael Okunewitch	Downgrade	Buy→Hold	—
Apr 16, 2026	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$4→$8
Mar 26, 2026	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
Mar 12, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$7
Feb 26, 2026	HC Wainwright & Co.	Matthew Caufield	PT Cut	Buy	$5→$4
Feb 25, 2026	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$15→$7
Jan 6, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$15
Jan 2, 2026	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$5
Nov 20, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$15
Nov 5, 2025	HC Wainwright & Co.	Matthew Caufield	PT Cut	Buy	$10→$5
Nov 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$15
Sep 12, 2025	HC Wainwright & Co.	Matthew Caufield	Maintained	Buy	$10
Sep 10, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Aug 5, 2025	HC Wainwright & Co.	Matthew Caufield	PT Raise	Buy	$10→$12
Aug 4, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Jul 29, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Jul 9, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Jun 17, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
May 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16

More with Benzinga EdgeGet Access

Analyst Ratings News

Snap To Rally More Than 217%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed outlook on top names. Complete view of analyst rating changes, including upgrades/downgrades, on analyst ratings page.

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $6

HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and lowers the price target from $8 to $6.

Benzinga Newsdesk

PRO
Maxim Group Downgrades FibroBiologics to Hold

Maxim Group analyst Michael Okunewitch downgrades FibroBiologics (NASDAQ:FBLG) from Buy to Hold.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Raises Price Target to $8

HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and raises the price target from $4 to $8.

Benzinga Newsdesk

PRO
D. Boral Capital Downgrades FibroBiologics to Hold

D. Boral Capital analyst Jason Kolbert downgrades FibroBiologics (NASDAQ:FBLG) from Buy to Hold.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $4

HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and lowers the price target from $5 to $4.

Benzinga Newsdesk

FibroBiologics Inc

FibroBiologics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

Snap To Rally More Than 217%? Here Are 10 Top Analyst Forecasts For Tuesday

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $6

PRO
Maxim Group Downgrades FibroBiologics to Hold

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Raises Price Target to $8

PRO
D. Boral Capital Downgrades FibroBiologics to Hold

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $4

People Also Watch

People Also Watch

FibroBiologics Inc

FibroBiologics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

Snap To Rally More Than 217%? Here Are 10 Top Analyst Forecasts For Tuesday

PROHC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $6

PROMaxim Group Downgrades FibroBiologics to Hold

PROHC Wainwright & Co. Maintains Buy on FibroBiologics, Raises Price Target to $8

PROD. Boral Capital Downgrades FibroBiologics to Hold

PROHC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $4

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $6

PRO
Maxim Group Downgrades FibroBiologics to Hold

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Raises Price Target to $8

PRO
D. Boral Capital Downgrades FibroBiologics to Hold

PRO
HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $4